Skip to main content

Featured

Nations React to Reported $1 Billion Fee for Trump’s Peace Board

  President Trump said the Peace Board 'will embark on a new approach to resolving global conflict'. Reports surrounding President Donald Trump’s proposed Board of Peace have ignited global debate after claims surfaced that countries may be asked to contribute $1 billion to secure or maintain permanent membership. The board, envisioned as a body overseeing governance and reconstruction efforts in Gaza, would reportedly be chaired by Trump himself, who would hold authority over which nations are admitted. A draft charter circulating among diplomats outlines three‑year membership terms, renewable only with the chairman’s approval. It also suggests that nations contributing $1 billion within the first year could bypass term limits and secure a permanent seat. The White House has pushed back on the reports, calling them misleading and insisting that no mandatory membership fee exists. Officials acknowledged that major financial contributors could receive greater influence but ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment